Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example Composition: M11 Report Section 7 (Participant Discontinuation) for A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example

Page standards status: Informative

version: 2; Last updated: 2026-05-30 22:59:15+0000

Profile: M11ReportSection07

ArtifactPublicationStatus: Active

url: https://fevir.net/resources/Composition/568064

identifier: FEvIR Object Identifier/568064

status: Final

type: CeSHarP Report

category: section7-participant-discontinuation

date: 2026-05-30 22:59:15+0000

author: Brian S. Alper, MD, MSPH

title: M11 Report Section 7 (Participant Discontinuation) for A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example

custodian: Computable Publishing LLC

relatesTo

type: Derived From

target: A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example

relatesTo

type: Cite As

target:

M11 Report Section 7 (Participant Discontinuation) for A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example [Database Entry: FHIR Composition Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 568064. Revised 2026-05-30. Available at: https://fevir.net/resources/Composition/568064. Computable resource at: https://fevir.net/resources/Composition/568064#json.